Diagnosis and management of epilepsy

CMAJ. Canadian Medical Association Journal

Volumn 168, Issue 4, 2003, Pages 441-448

  Blume, Warren T ^a  

^a LONDON HEALTH SCIENCES CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN; ANTICONVULSIVE AGENT; BARBITURIC ACID DERIVATIVE; CARBAMAZEPINE; ESTRADIOL; ESTROGEN; ETHOSUXIMIDE; FOLIC ACID; GABAPENTIN; LAMOTRIGINE; ORAL CONTRACEPTIVE AGENT; OXCARBAZEPINE; PHENOBARBITAL; PHENYTOIN; PRIMIDONE; PROGESTERONE; TOPIRAMATE; VALPROIC ACID; VITAMIN K GROUP;

ABSENCE; AMNION FLUID ANALYSIS; ANTICONVULSANT THERAPY; BENIGN CHILDHOOD EPILEPSY; BRAIN SURGERY; BREAST FEEDING; CATAMENIAL EPILEPSY; CLEFT LIP; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CONGENITAL HEART DISEASE; CONTRACEPTION; DIAGNOSTIC ERROR; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; DRIVING ABILITY; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG EXCRETION; DRUG MILK LEVEL; DRUG SAFETY; ELECTROENCEPHALOGRAPHY; EPILEPSY; FETUS DEATH; FETUS DISTRESS; FETUS MALFORMATION; FOCAL EPILEPSY; FOLIC ACID BLOOD LEVEL; GRAND MAL SEIZURE; HEART ARRHYTHMIA; HORMONE BLOOD LEVEL; HORMONE METABOLISM; HUMAN; HYDROCEPHALUS; HYPERTELORISM; LOW SET EAR; MATERNAL NUTRITION; MONOTHERAPY; MYOCLONUS EPILEPSY; NAIL HYPOPLASIA; NEURAL TUBE DEFECT; NEUROLOGIC EXAMINATION; NEWBORN HEMORRHAGIC DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; PALATE MALFORMATION; PHYSICIAN ATTITUDE; PREGNANCY; PSYCHOLOGIC ASSESSMENT; REVIEW; SIDE EFFECT; TEMPORAL LOBE EPILEPSY; TERATOGENESIS; TREATMENT OUTCOME; VITAMIN SUPPLEMENTATION;

EID: 0037452661     PISSN: 08203946     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (31)

1. Kuyk J, Leijten F, Meinardi H, Spinhoven, Van Dyck R. The diagnosis of psychogenic non-epileptic seizures: a review. Seizure 1997;6:243-53.
2. Canadian Pharmacists Association. Tegretol. Compendium of pharmaceuticals and specialties. Ottawa: The Association; 2002. p. 1666-8.
3. Canadian Pharmacists Association. Lamictal. Compendium of pharmaceuticals and specialties. Ottawa: The Association; 2002. p. 866-70.
4. Canadian Pharmacists Association. Dilantin. Compendium of pharmaceuticals and specialties. Ottawa: The Association; 2002. p. 509-12.
5. Canadian Pharmacists Association. Topamax. Compendium of pharmaceuticals and specialties. Ottawa: The Association; 2002. p. 1709-13.
6. Canadian Pharmacists Association. Epival. Compendium of Pharmaceuticals and Specialties. Ottawa: The Association; 2002. p. 582-6.
7. Canadian Pharmacists Association. Zarontin. Compendium of Pharmaceuticals and Specialties. Ottawa: The Association; 2002. p. 1899.
8. Levy RH, Dreifuss FE, Mattson RH, Meldrum BS, Penry JK. Antiepileptic drugs. 3rd ed. New York: Raven Press; 1989.
9. Levy RH, Mattson RH, Meldrum BS. Antiepileptic drugs. 4th ed. New York: Raven Press; 1995.
10. Wyllie E. The treatment of epilepsy, principles & practice. 3rd ed. Philadelphia: Lippincott Williams & Wilkins; 2001.
11. Blume WT. Epilepsy with generalised tonic-clonic seizures on awakening and other idiopathic generalised epilepsies. In: Meinardi H, editor. The epilepsies, Part II. Vol 73 (29) of Handbook of clinical neurology series. Amsterdam: Elsevier Science; 2000. p. 175-82.
12. Van Huffelen AC, van der Meij W. Idiopathic partial epilepsies. In: Meinardi H, editor. The epilepsies, Part II. Vol 73 (29) of Handbook of clinical neurology series. Amsterdam: Elsevier Science; 2000. p. 5-35.
13. Loiseau P. Idiopathic and benign partial epilepsies. In: Wyllie E, editor. The treatment of epilepsy. Principles and practice. 3rd ed. Philadelphia: Lippincott Williams & Wilkins; 2001. p. 475-84.
14. Karceski S, Morrell M, Carpenter D. The expert consensus guideline series. Treatment of epilepsy. Epilepsy Behav 2001;(Suppl 2):A1-50.
15. Friis ML, Lund M. Stress convulsions. Arch Neurol 1974;31:155-9.
16. Bardy AH. Decisions after first seizure. Acta Neurol Scand 1991;83:294-6.
17. Berg AT, Shinnar S. The risk of seizure recurrence following a first unprovoked seizure: a quantitative review. Neurology 1991;41:965-72.
18. Shinnar S, Berg AT, Moshe SL, Petix M, Maytal J, Kang H, et al. Risk of seizure recurrence following a first unprovoked seizure in childhood: a prospective study. Pediatrics 1990;85:1076-85.
19. Camfield PR, Camfield CS, Dooley JM, Tibbles JA, Fung T, Garner B. Epilepsy after a first unprovoked seizure in childhood. Neurology 1985;35:1657-60.
20. Camfield C, Camfield P, Gordon K, Dooley J. Does the number of seizures before treatment influence ease of control or remission of childhood epilepsy? Not if the number is 10 or less. Neurology 1996;46:41-4.
21. First Seizure Trial Group. Randomized clinical trial on the efficacy of antiepileptic drugs in reducing the risk of relapse after a first unprovoked tonic-clonic seizure. Neurology 1993;43:478-83.
22. Klein P, Herzog AG. Hormones and epilepsy. In: Schmidt D, Schachter SC, editors. Epilepsy: problem solving in clinical practice. London: Martin Dunitz; 2000. p. 413-33.
23. Foldvary N. Treatment of epilepsy during pregnancy. In: Wyllie E, editor. The treatment of epilepsy principles and practice. 3rd ed. Philadelphia: Lippincott Williams & Wilkins; 2001. p. 775-86.
24. Lindhout D. Pregnancy and epilepsy. In: Schmidt D, Schachter SC, editors. Epilepsy: problem solving in clinical practice. London: Martin Dunitz; 2000. p. 241-52.
25. Sadler RM. Women's issues and epilepsy. Mississauga (ON): The Medicine Group; 2002. Merritt-Putnam Neurology Residents' Course.
26. Canadian Pharmacists Association. Folic acid. Compendium of pharmaceuticals and specialties. Ottawa: The Association; 2002. p. 658-9.
27. Canadian Pharmacists Association. Vitamin K. Compendium of pharmaceuticals and specialties. Ottawa: The Association; 2002. p. 1842-3.
28. Canadian Pharmacists Association. Special Access Programme. Compendium of pharmaceuticals and specialties. Ottawa: The Association; 2002. p. A7.
29. Parker BM, Vestal RE. Pharmacokinetics of anticonvulsant drugs in the elderly. In: Wyllie E, editor. The treatment of epilepsy, principles and practice. Philadelphia: Lea & Febiger; 1993. p. 769-74.
30. Canadian Medical Association. Determining medical fitness to drive. 6th ed. Ottawa: The Association; 2000.
31. McLachlan R. Epilepsy and driving. Mississauga (ON): The Medicine Group; 2002. p. 44-7. Merritt-Putnam Neurology Residents' Course.